Tu Youyou is a Chinese medical scientist. In 2015 she won the Nobel Prize in Physiology or Medicine for discovering artemisinin, a malaria drug that has saved millions of lives. She was born on 30 December 1930 in Ningbo, a city on China's east coast. Her family valued education. As a teenager, Tu caught tuberculosis and had to take two years off school. The experience pushed her toward medicine. When she returned to school, she knew she wanted to help fight disease. She studied at Beijing Medical College and graduated in 1955. She then joined the Institute of Materia Medica at the Academy of Traditional Chinese Medicine. From 1959 to 1962 she took a special course that taught modern-trained scientists about traditional Chinese medicine. This combination shaped the rest of her career. In 1969, at age 39, she was put in charge of a research team on a secret Chinese government project called Project 523. The goal was to find a new malaria treatment. Over the next few years, Tu and her team worked through thousands of traditional herbal remedies. She found her answer in a 1,600-year-old Chinese medical book. The compound she isolated, now called artemisinin, became one of the most important drugs of the twenty-first century. She did this work without a PhD, without any study abroad, and without membership in the Chinese Academy of Sciences. Some Chinese call her the 'three-nos professor'. She was promoted to senior researcher in 1980. She is still active at the China Academy of Chinese Medical Sciences.
Tu Youyou matters for three reasons. First, artemisinin has saved many millions of lives. Malaria is one of the deadliest diseases in human history. It kills mostly children in Africa. Before artemisinin, malaria parasites had become resistant to older drugs. Without a new treatment, malaria deaths would have kept rising. Artemisinin-based combination therapies are now the standard malaria treatment around the world. The World Health Organization estimates they have prevented millions of deaths since they were introduced.
Second, her method shows a new way to combine traditional and modern medicine. Traditional Chinese medicine has thousands of remedies built up over centuries. Most are not well tested by modern science. Tu took the tradition seriously. She read old medical texts carefully. Then she used modern chemistry to test and refine what the old texts suggested. Her approach is now a model for medical research in places where traditional knowledge is still alive.
Third, she is an example of modest, persistent science in a system that did not always reward her. She worked during the Cultural Revolution, when much Chinese research was disrupted. She had no PhD and no study abroad. She had no famous laboratory. She tested artemisinin on herself before giving it to patients. Her results were published anonymously for years. She got credit only decades later. Her story shows that good science can happen in difficult conditions and that individual credit sometimes arrives very late.
For a first introduction, the official Nobel Prize website has clear biographical material about Tu Youyou. Her own Nobel lecture from December 2015 is available as a video with English subtitles. The BBC News coverage of her 2015 prize is readable and accessible. A good short article is 'The Secret Chinese Operation That Conquered Malaria' in Fortune (October 2015). For students who want a visual introduction, various documentary segments on YouTube cover her career and Project 523.
For deeper reading, Louis H. Miller and Xinzhuan Su's article 'The Discovery of Artemisinin and the Nobel Prize in Physiology or Medicine' in Cell (2011) gives the scientific context. Tu's own book From Artemisia annua L. to Artemisinins (2017) describes her work in detail. Elisabeth Hsu's Reflection on Nobel Prize Laureate Tu Youyou and the Medical Use of Artemisia Annua is valuable on the Chinese medical context. The World Health Organization's reports on malaria treatment explain how artemisinin combination therapies work in the field.
Tu Youyou used traditional Chinese medicine directly to treat malaria.
She did not. She used traditional texts as a source of ideas, then applied modern chemistry to isolate a pure compound. The remedies described by Ge Hong and others used whole plants in various forms. Artemisinin is a specific chemical substance Tu's team extracted, purified, and tested. The final drug is modern medicine informed by traditional knowledge, not traditional medicine itself. This distinction matters. Many people claim their favourite herb cures diseases because 'the tradition says so'. Tu's approach required rigorous testing. Only a small number of traditional remedies produced compounds that actually worked.
The discovery of artemisinin was a lucky accident.
It was the result of years of systematic work. Tu's team screened thousands of plants and tested hundreds of extracts. They failed many times before succeeding. The key insight (using cold instead of hot extraction) came from careful reading of Ge Hong's ancient text, combined with modern understanding of chemistry. This is not luck. It is patient, attentive work. Calling it luck underestimates the effort required and misses what students can actually learn from Tu's example.
Tu was internationally famous immediately after her discovery.
She was largely unknown outside China for decades. Her work was published anonymously in 1977. She presented to the World Health Organization only in 1981. Her role became widely recognised internationally only in the 2000s. The 2015 Nobel Prize made her a global figure, forty-four years after the actual discovery. Her story is an example of how long real recognition can take, especially for scientists working outside the main Western academic networks.
Winning the Nobel Prize means the malaria problem is now solved.
Artemisinin has saved millions of lives, but malaria still kills around half a million people each year, mostly children in Africa. Resistance to artemisinin has begun to appear in Southeast Asia. The drug is now given in combination with others to slow this. New research is needed constantly. Tu herself has warned about these problems. A major scientific achievement does not always mean permanent victory. Diseases evolve. Science must keep working.
For research-level engagement, Jia-Rui Chong's The Man Who Made Artemisinin, the academic controversies around single-author recognition for Nobel 2015, and the broader history of Project 523 are all worth reading. Marta Hanson's work on medical history in modern China is excellent. The journal Asian Medicine covers the intersection of traditional Chinese medicine and modern science. For the chemistry, Paul O'Neill, Victoria Barton, and Stephen Ward's academic reviews on antimalarial chemistry are standard references. For the ongoing problem of artemisinin resistance, World Health Organization technical reports are essential.
Your feedback helps other teachers and helps us improve TeachAnyClass.